Novel ALK gene mutation in inflammatory myofibroblastic tumor of the thyroid: a case report
BackgroundInflammatory myofibroblastic tumor (IMT) is a rare soft tissue neoplasm, exceptionally uncommon in the thyroid. Approximately 50%–70% of IMT cases exhibit ALK gene rearrangements or fusions, while ALK point mutations are rare. We report a novel ALK gene mutation, ALK-R395H, in a case of th...
Saved in:
| Main Authors: | Yang Guangxu, Li Yao, Xie Jing, Liu Hongsheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1616075/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel PLEC-EML4-ALK Double Fusion Underlying Crizotinib Resistance in a Metastatic Inflammatory Myofibroblastic Tumor: A Case Report
by: Alessandra Maleddu, MD, et al.
Published: (2025-05-01) -
Case Report: Intestinal metastasis from ALK-rearranged pulmonary pleomorphic carcinomas mimicking inflammatory myofibroblastic tumors
by: Changle Shi, et al.
Published: (2025-03-01) -
Renal Inflammatory Myofibroblastic Tumor in an Infant: Case Report with Review of Literature
by: Vinayak Dave, et al. -
Case Report: Clinical response of ensartinib for inflammatory myofibroblastic tumor of the urinary bladder with multiple metastases and TPM4-ALK fusion
by: Hongtao Ren, et al.
Published: (2025-05-01) -
Inflammatory myofibroblastic tumors in children: clinical characteristics and treatment outcomes with a focus on targeted therapies
by: Ülkü Miray Yıldırım, et al.
Published: (2025-02-01)